$SBUX · Starbucks
Latest call · 2026-04-28
The call
Head-to-head · Claude vs the Street vs reality
| Claude | Street | Actual | |
|---|---|---|---|
| EPS | $0.46 | $0.43 | ⏳ pending |
| Revenue | $9.27B | $9.16B | — |
| Direction (1d) | 🟢 UP |
🟡 FLAT
14B · 12H · 2S
|
— |
| 1d move | +4.0% | — | — |
| 3d move | +6.0% | — | — |
Thesis
Starbucks goes into print with the implied move at 6.94% — the market expects a big surprise. The Niccol turnaround has compounding catalysts: Stifel mobile data shows US comps tracking +4.5-5% (above guide), China franchising removes the biggest overhang, and product simplification flows op-margin. The 50% Buy rating mix means analysts are still skeptical — they'll be upgrading after the print, not before.
What would flip it
A weak China franchise sale headline (<$2B) or April US comp decel from tariff pullback flips this to a -3% sell-the-news.
The market's narrative
Niccol turnaround story already priced into a base near $100; Street modeling +3-4% comps in line with management guide; consensus skeptical (50% Buy mix) on whether US transactions can sustainably inflect.
Where the Street may be wrong
- Stifel's mobile location data shows US comps tracking +4.5-5%, above the +3-4% guide — two sequential quarters of US transactions growth is the bull-case checkpoint.
- China franchising decision removes the largest analyst overhang — opex one-time gain plus structural margin lift in segments analysts haven't fully modeled.
- Niccol-led product simplification + back-to-Starbucks merchandising = operating leverage flowing through op-margin even on modest topline beat.
Peer read: MCD pre-released constructive April US comp commentary; CMG (4/23) printed +4.4% comps confirming breakfast/lunch traffic resilient.
Reasoning
- Implied 6.94% move = market pricing big surprise either direction; biased UP because turnaround momentum has compounding catalysts.
- US transactions inflection + China de-risk + margin leverage = trifecta of independent positive surprises.
- Niccol has hit every prior checkpoint — execution credibility supports the lean-in into print.
- 50% Buy mix on a quality compounder turnaround = analysts behind the curve, will upgrade post-print.
- Implied move/median move ratio supports lean into the print rather than fading.
Risks to the call
- China franchise sale terms disappoint vs the structural-uplift case (any < $2B headline number).
- US transactions decel back to negative on tariff-driven consumer pullback in the back-half of Mar.